Erste randomisierte Phase-3-Studie zur adjuvanten Therapie mit einem Tyrosinkinaseinhibitor bei Hochrisiko-Nierenzellkarzinom = First randomized phase 3 study on adjuvant therapy with a tyrosine kinase inhibitor in high-risk renal cell carcinoma
No Abstract available for this article.
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | German |
| Published: |
10. August 2016
|
| In: |
Der Onkologe
Year: 2016, Volume: 22, Issue: 11, Pages: 886-888 |
| ISSN: | 1433-0415 |
| DOI: | 10.1007/s00761-016-0096-3 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1007/s00761-016-0096-3 Verlag, Volltext: https://link.springer.com/article/10.1007/s00761-016-0096-3 
|
| Author Notes: | Carsten Grüllich |
| Summary: | No Abstract available for this article. |
|---|---|
| Item Description: | Gesehen am 25.08.2017 |
| Physical Description: | Online Resource |
| ISSN: | 1433-0415 |
| DOI: | 10.1007/s00761-016-0096-3 |